Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2006 1
2011 2
2012 1
2013 1
2019 1
2021 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
The impact of curative conversion therapy aimed at a cancer-free state in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab.
Shimose S, Iwamoto H, Shirono T, Tanaka M, Niizeki T, Kajiwara M, Itano S, Yano Y, Matsugaki S, Moriyama E, Noda Y, Nakano M, Kuromatsu R, Koga H, Kawaguchi T. Shimose S, et al. Among authors: matsugaki s. Cancer Med. 2023 Jun;12(11):12325-12335. doi: 10.1002/cam4.5931. Epub 2023 Apr 16. Cancer Med. 2023. PMID: 37062077 Free PMC article.
A case of postirradiation angiosarcoma of the greater omentum with hemorrhage.
Sakemi M, Sakemi R, Harada M, So S, Uchiyama D, Morimitsu Y, Kakiuchi S, Ishihara Y, Kubo Y, Matsugaki S, Ono T, Takane J, Sasaki E, Shimokobe M, Sata M. Sakemi M, et al. Among authors: matsugaki s. Clin J Gastroenterol. 2011 Oct;4(5):302-306. doi: 10.1007/s12328-011-0245-6. Epub 2011 Jul 30. Clin J Gastroenterol. 2011. PMID: 26189629
Survival Benefit of Hepatic Arterial Infusion Chemotherapy over Sorafenib in the Treatment of Locally Progressed Hepatocellular Carcinoma.
Iwamoto H, Niizeki T, Nagamatsu H, Ueshima K, Nomura T, Kuzuya T, Kasai K, Kooka Y, Hiraoka A, Sugimoto R, Yonezawa T, Ishihara A, Deguchi A, Arai H, Shimose S, Shirono T, Nakano M, Okamura S, Noda Y, Kamachi N, Sakai M, Suzuki H, Aino H, Matsukuma N, Matsugaki S, Ogata K, Yano Y, Ueno T, Kajiwara M, Itano S, Fukuizumi K, Kawano H, Noguchi K, Tanaka M, Yamaguchi T, Kuromatsu R, Kawaguchi A, Koga H, Torimura T, New Fp Study Group, Kurume Liver Cancer Study Group Of Japan. Iwamoto H, et al. Among authors: matsugaki s. Cancers (Basel). 2021 Feb 5;13(4):646. doi: 10.3390/cancers13040646. Cancers (Basel). 2021. PMID: 33562793 Free PMC article.
Efficacy, safety, and survival factors for sorafenib treatment in Japanese patients with advanced hepatocellular carcinoma.
Nakano M, Tanaka M, Kuromatsu R, Nagamatsu H, Sakata K, Matsugaki S, Kajiwara M, Fukuizumi K, Tajiri N, Matsukuma N, Sakai T, Ono N, Yano Y, Koga H, Kurogi J, Takata A, Sumie S, Satani M, Yamada S, Niizeki T, Aino H, Iwamoto H, Torimura T, Sata M. Nakano M, et al. Among authors: matsugaki s. Oncology. 2013;84(2):108-14. doi: 10.1159/000342650. Epub 2012 Nov 9. Oncology. 2013. PMID: 23147476
[A case of IgG4-related sclerosing disorders involving the mesentery and the pancreas].
Sakemi R, So S, Morimitsu Y, Uchiyama D, Kakiuchi S, Ishihara Y, Matsushima Y, Kubo Y, Matsugaki S, Ono T, Takane J, Sasaki E, Sakemi M, Shimokobe M, Sata M. Sakemi R, et al. Among authors: matsugaki s. Nihon Shokakibyo Gakkai Zasshi. 2011 Jun;108(6):969-77. Nihon Shokakibyo Gakkai Zasshi. 2011. PMID: 21646765 Japanese.
Prophylactic lamivudine administration prevents exacerbation of liver damage in HBe antigen positive patients with hepatocellular carcinoma undergoing transhepatic arterial infusion chemotherapy.
Nagamatsu H, Itano S, Nagaoka S, Akiyoshi J, Matsugaki S, Kurogi J, Tajiri N, Yamasaki S, Koga H, Torimura T, Kumashiro R, Sata M. Nagamatsu H, et al. Among authors: matsugaki s. Am J Gastroenterol. 2004 Dec;99(12):2369-75. doi: 10.1111/j.1572-0241.2004.40069.x. Am J Gastroenterol. 2004. PMID: 15571585
Value of fusing PET plus CT images in hepatocellular carcinoma and combined hepatocellular and cholangiocarcinoma patients with extrahepatic metastases: preliminary findings.
Nagaoka S, Itano S, Ishibashi M, Torimura T, Baba K, Akiyoshi J, Kurogi J, Matsugaki S, Inoue K, Tajiri N, Takada A, Ando E, Kuromatsu R, Kaida H, Kurogi M, Koga H, Kumashiro R, Hayabuchi N, Kojiro M, Sata M. Nagaoka S, et al. Among authors: matsugaki s. Liver Int. 2006 Sep;26(7):781-8. doi: 10.1111/j.1478-3231.2006.01296.x. Liver Int. 2006. PMID: 16911459